Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-20-029638
Filing Date
2020-10-01
Accepted
2020-10-01 17:27:50
Documents
12

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea127698-424b4_aptorumgroup.htm 424B4 1440994
2 GRAPHIC image_002.jpg GRAPHIC 78067
3 GRAPHIC image_003.jpg GRAPHIC 185070
4 GRAPHIC image_004.jpg GRAPHIC 22666
5 GRAPHIC image_005.jpg GRAPHIC 12499
6 GRAPHIC image_006.jpg GRAPHIC 36563
7 GRAPHIC image_007.jpg GRAPHIC 16856
8 GRAPHIC image_008.jpg GRAPHIC 66227
9 GRAPHIC image_009.jpg GRAPHIC 8224
10 GRAPHIC image_010.jpg GRAPHIC 175660
11 GRAPHIC image_011.jpg GRAPHIC 656392
12 GRAPHIC image_012.jpg GRAPHIC 78067
  Complete submission text file 0001213900-20-029638.txt   3266895
Mailing Address 17 HANOVER SQUARE LONDON X0 W1S 1BN
Business Address 17 HANOVER SQUARE LONDON X0 W1S 1BN 852 3953 7700
Aptorum Group Ltd (Filer) CIK: 0001734005 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-248743 | Film No.: 201217226
SIC: 2834 Pharmaceutical Preparations